Aim: To investigate the protective effects of hydrogen sulfide (H 2 S) against inflammation, oxidative stress and apoptosis in a rat model of resuscitated hemorrhagic shock. Methods: Hemorrhagic shock was induced in adult male SD rats by drawing blood from the femoral artery for 10 min. The mean arterial pressure was maintained at 35-40 mmHg for 1.5 h. After resuscitation the animals were observed for 200 min, and then killed. The lungs were harvested and bronchoalveolar lavage fluid was prepared. The levels of relevant proteins were examined using Western blotting and immunohistochemical analyses. NaHS (28 μmol/kg, ip) was injected before the resuscitation. Results: Resuscitated hemorrhagic shock induced lung inflammatory responses and significantly increased the levels of inflammatory cytokines IL-6, TNF-α, and HMGB1 in bronchoalveolar lavage fluid. Furthermore, resuscitated hemorrhagic shock caused marked oxidative stress in lung tissue as shown by significant increases in the production of reactive oxygen species H 2 O 2 and ·OH, the translocation of Nrf2, an important regulator of antioxidant expression, into nucleus, and the decrease of thioredoxin 1 expression. Moreover, resuscitated hemorrhagic shock markedly increased the expression of death receptor Fas and Fas-ligand and the number apoptotic cells in lung tissue, as well as the expression of pro-apoptotic proteins FADD, active-caspase 3, active-caspase 8, Bax, and decreased the expression of Bcl-2. Injection with NaHS significantly attenuated these pathophysiological abnormalities induced by the resuscitated hemorrhagic shock. Conclusion: NaHS administration protects rat lungs against inflammatory responses induced by resuscitated hemorrhagic shock via suppressing oxidative stress and the Fas/FasL apoptotic signaling pathway.
Introduction
In recent years, H 2 S has been recognized, along with nitric oxide (NO) and carbon monoxide (CO), as a third gaseous signaling molecule [1] . It is generally agreed that H 2 S exerts a variety of protective effects on multiple organs in pathophysiological processes. H 2 S has been reported to function as an anti-oxidant and is able to improve cardiac function, limit leukocyte adhesion and to enhance angiogenesis in a number of animal models [2] [3] [4] [5] . Additionally, researchers have dem-# These authors contributed equally to this article. * To whom correspondence should be addressed.
onstrated that H 2 S administration may induce a "suspended animation-like state" in small mammals such as mice and rats [6, 7] but not in larger mammals such as pigs [8] . There have recently been a number of large studies that were designed to investigate the beneficial effects of H 2 S on important organs. Jiang and colleagues demonstrated that, in rats, exogenous H 2 S alleviates heroin-induced hippocampal damage through its antioxidant and anti-apoptotic effects [9] . Another group of researchers has shown the protective effects of H 2 S on the hepatotoxicity induced by acetaminophen in mice [10] . A study by Lee et al proposed that hydrogen sulfide inhibits the increased glucose-induced matrix protein synthesis in renal epithelial cells [11] . Similarly, hydrogen sulfide has also been shown to attenuate hyperhomocysteinemia-induced cardiomyocytic endoplasmic reticulum stress in rats [12] . A recent study in pigs has shown that intravenous sulfide administration protects multiple organs against hemorrhagic shock (HS) [13] . Studies have also suggested that hydrogen sulfide protects against lipopolysaccharide-induced acute lung injury [14] . Finally, a new study has recently shown that hydrogen sulfide decreases the generation of reactive oxygen species in a rabbit model of lung transplantation [15] . Hemorrhagic shock has been recognized as a predictor of poor outcome and as a leading cause of death in injured patients worldwide. The pathophysiologic process of HS is complex, and involves, among other events, hypovolemia, hypoxemia, microcirculatory disturbances, oxidative stress, the release of significant amounts of toxic chemical mediators, and apoptosis [16] . These alterations during HS are the primary cause of the subsequent development of multiple organs failure (MOF), a systemic inflammatory process that leads to the dysfunction of vital organs and that results in a high mortality rate [17] . Important organs, such as the lungs, are susceptible to such changes. The mechanisms that lead to organ injury induced by HS have not been fully elucidated; however, apoptosis is considered to be an underlying factor in acute lung injury [18] . It is well-established that lipopolysaccharide-induced acute lung injury is associated with apoptosis involving Fas/FasL interactions [19] . Although different from the cell death patterns observed during LPS-induced lung injury, hyperoxia and ischemia-reperfusion injury are the main causes of complex cell death that include apoptosis, oncosis, and necrosis [20, 21] . Dimtrios and colleagues have suggested that two programmed cell death pathways exist in the lungs in rat models of trauma-hemorrhagic shock [22] . These two pathways involve endothelial cell death via a caspase-independent way and epithelial cell apoptosis through a caspase-dependent pathway.
Given the various protective effects of H 2 S mentioned above, we explored the anti-inflammatory, anti-oxidant, and antiapoptotic effects of H 2 S in a rat model of hemorrhagic shock induced acute lung injury.
Materials and methods

Materials
NaHS and pentobarbital sodium were purchased from Sigma (Sigma-Aldrich CO LLC, MO, USA). Tumor necrosis factor α (TNF-α) and interlukin-6 (IL-6) ELISA kits were obtained from R&D (R&D Systems Inc, Minneapolis, MN, USA). The primary antibodies against high mobility group box 1 (HMGB1) and thioredoxin 1 (Trx1) were purchased from Epitomics (Epitomics, CA, USA). The primary antibody against nuclear erythroid-2 related factor 2 (Nrf2) was from Bioworld Technology (Nanjing, China). The anti-rat monocytes/macrophages antibody (ED1) was purchased from the Millipore Corporation. The commercial kits for hydrogen peroxide (H 2 O 2 ), hydroxyl radical (·OH) and malondialdehyde (MDA) were obtained from the Jiancheng Bioengineering Institute (Nanjing, China). The primary antibodies against Fas, FasL, active-caspase 8, active-caspase 3, FADD, BID, Bcl-2, and Bax were all purchased from Abcam (Abcam, Cambridge, UK).
The commercial immunohistochemistry staining kit was from ZSGB-BIO CO Ltd (Beijing, China). A commercial in situ cell death detection kit was from Roche Ltd (Basel, Switzerland). An ECL kit for signal detecting was purchased from BestBio Inc (Shanghai, China).
Animals
We used age-matched adult male Sprague-Dawley (SD) rats that weighed 250-350 g with an average weight of approximate 280 g in this study. All the animals were from the Animal Center of the Fourth Military Medical University (Xian, China) and received humane care in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No 85-23, revised 1996). The protocol number from the Human and Animal Ethics Committee of the Fourth Military Medical University is DSJY-DXLL-2012510. All animals were fed a standard rodent diet (purchased from the Animal Center of the Fourth Military Medical University).
Animal groups and the hemorrhagic shock model A total of 32 rats were used in the present study. The animals were randomly assigned to 4 groups (8 rats for each group) as follows: (1) Sham-operated animals (Sham group); (2) Sham-operated animals that were treated with sodium sulfide (NaHS) (Sham+NaHS group); (3) hemorrhagic shock animals (HS group); and (4) hemorrhagic shock animals that were treated with NaHS (HS+NaHS group). After 1 week of acclimatization, the rats were fasted overnight prior to the experiments but were allowed free access to water. The rat hemorrhagic shock model was performed as has previously been described [23] . The optimal dose of NaHS (28 μmol/kg) to be administered to the animals was determined by our preliminary experiments (See the Supplemental data). In brief, blood was drawn from the femoral artery of the rats over a 10-min period to induce a mean arterial pressure (MAP) of 35-40 mmHg and to maintain a condition of shock for 1.5 h. One bolus dose of NaHS (28 μmol/kg, ip) was administered to the rats before resuscitation. The rats were observed for 200 min after the resuscitation. The rats in the HS group underwent all of the surgical procedures and were given 0.9% NaCl in place of an equal volume of the NaHS solution before resuscitation. The rats in the Sham group also underwent all of the surgical procedures but neither hemorrhage nor resuscitation was performed. The rats in the Sham+NaHS group underwent the same procedure as did the Sham group, except that the NaHS was administered at the time of resuscitation. All of the experimental animals were sacrificed by injection with an overdose of pentobarbital sodium after the procedures were completed. The lungs were harvested immediately, and the left lower lobes were sectioned into 3-mm-thick slices that were immersed in 10% formalin for subsequent analysis. Part of the left lung was cut and weighed to obtain the wet lung weight. Bronchoalveolar lavage of the right lung was then performed. The remaining lung tissue was stored in a -70 °C freezer for subsequent analyses.
Lung wet to dry ratio and morphological investigation
The lung wet to dry weight ratios were calculated to assess the magnitude of pulmonary edema induced by the hemorrhagic shock. After the wet lungs were weighed, they were desiccated in an oven at 80 °C for 72 h to obtain a stable dry weight. The ratio of the wet/dry weight was then calculated. To investigate the morphological changes in the lungs induced by hemorrhagic shock, hematoxylin and eosin staining (HE) was performed according to a standard protocol. To evaluate the degree of the morphological changes in the lung tissue, the HE stained slides were analyzed by a pathologist who was blinded to the identity of the experimental groups.
Bronchoalveolar lavage fluid preparation and analysis of inflammatory cytokines At the end of the experiment, bronchoalveolar lavage of the right lung was performed on all of the experimental groups (n=8, respectively) by washing the lung five times with 1 mL of phosphate-buffered saline. Approximately 90% (4.5 mL) of the starting lavage fluid volume was consistently retrieved. The bronchoalveolar lavage fluid was centrifuged at 450×g for 10 min, and the supernatant was then stored at -70 °C for later analysis. The concentration of protein in the lavage fluid was measured using Bradford's method with bovine serum albumin used as a standard [24] . The concentrations of TNF-α and IL-6 in the bronchoalveolar lavage fluid were determined using commercially available ELISA kits (R&D Systems Inc, Minneapolis, MN, USA) according to the manufacturer's instructions. In brief, after the lavage samples were collected, the samples and reagents were added to the assay wells in order and the optical densities were read by a spectrophotometer (PowerWave XS, BioTek Inc, VT, USA) at 450 nm (with a correction wavelength at 540 nm). Then, the concentrations of TNF-α and IL-6 were calculated accordingly.
Myeloperoxidase assays
Myeloperoxidase (MPO) activity was measured using a commercially available kit (Jiancheng Bioengineering Institute, Nanjing, China) to assess the neutrophilic infiltration into the lung. In short, lung samples from each group were homogenized in ice cold saline (with a 1:10 ratio of lung tissue to saline). The homogenates were then processed according to the manufacturer's instructions. Finally, myeloperoxidase was detected using a spectrophotometer at 460 nm (PowerWave XS, BioTek Inc, VT, USA), and the MPO activity was thereby obtained.
Oxidative stress analysis H 2 O 2 and ·OH were used as a surrogate for the production of reactive oxygen species during HS induced oxidative stress in vivo. The lung tissue was homogenized in 0.01 mol/L phosphate buffered saline (PBS, pH 7.4). After centrifugation at 1200×g for 10 min at 4 °C, the supernatant was collected and the reagents were added according to the manufacturer's instructions. The absorbance was detected using a spectrophotometer at 560 nm, and the concentrations of H 2 O 2 and ·OH were then calculated.
Terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) staining A commercial in situ cell death detection kit (Roche Ltd, Basel, Switzerland) was used in this study according to the manufacturer's instructions. In brief, the tissue sections were dewaxed according to standard protocols and then were microwave heat treated. The slides were immersed in Tris-HCl (0.1 mol/L, pH 7.5) containing 3% BSA and 20% normal bovine serum for 30 min. To exclude the staining of apoptotic inflammatory cells that are present in the lungs after HS, the slides were incubated with an antibody against ED1 (1:200, Millipore, Billerica, MA, USA) overnight before proceeding with the staining. The corresponding secondary antibody was incubated for 60 min at 37 °C. After being washed twice in PBS, the slides were covered with the TUNEL reaction mixture. The slides were then incubated for 60 min at 37 °C in a humidified chamber in the dark. Then, the slides were washed three times with PBS for 5 min each. The apoptotic cells were counted by a pathologist under a fluorescence microscope. The apoptotic cells in 10 consecutive visual fields were counted in each histological section using a ×40 objective.
Immunohistochemistry (IHC) assays
After being dewaxed, the paraffin sections (4 μm thick) were incubated at 4 °C overnight in the presence of primary antibodies raised against HMGB1 (1:200, Epitomics, CA, USA), Fas (1:150, Abcam, Cambridge, UK), and Fas ligand (1:150, Abcam, Cambridge, UK). Then, the sections were incubated with the appropriate secondary antibodies at 37 °C for 1 h. The final antibody complex was visualized using a commercial immunohistochemistry staining kit (ZSGB-BIO CO Ltd, Beijing, China). The stained sections were analyzed using ImagePro Plus software (version 6.0, Media Cybernetics, Inc, MD, USA) by a pathologist who was blinded to the identity of the groups. The integrated optical density (IOD) was calculated by measuring 10 consecutive visual fields for each sample using a 40×objective. All data were gathered and used to calculate a mean value. A statistical analysis was used to compare the results obtained from different experimental groups.
Western blotting assays
The lung tissue samples were homogenized in 1 mL of icecold RIPA lysis buffer (Beyotime Inc, Haimen, China). The homogenates were then centrifuged at 800×g to remove the cellular debris. After the pellet had been discarded, the supernatant was again centrifuged at 12 000×g for 10 min at 4 °C. The resulting supernatant (cytosolic fraction) was collected. The resulting pellet was resuspended in mitochondrial lysis buffer to obtain the mitochondrial fraction. The nuclear protein was extracted using a commercial kit (BestBio Inc, Shanghai, China) according to the manufacturer's instructions. Equivalent amounts of protein (30 μg) from each sample were separated on 12% SDS-polyacrylamide gels and were then transferred onto 0.22 μmol/L nitrocellulose filter membranes 
Results
NaHS alleviates lung injury in a rat model of hemorrhagic shock
The pulmonary histology observed microscopically showed that the lung structure was normal with well-defined pulmonary alveoli in the Sham and Sham+NaHS groups ( Figure 1A and 1B). Furthermore, hemorrhagic shock caused acute alveolar injury and inflammation ( Figure 1C) ; the histopathologic changes in the lung were characterized by the aggregation of red blood cells, edema, the infiltration of inflammatory cells, markedly thickened alveolar walls, and the destruction of alveoli. The NaHS treatment notably attenuated these features of lung injury ( Figure 1D ). The wet to dry ratios of the lungs were calculated to assess the edema induced by hemorrhagic shock. HS increased the wet to dry ratio ( Figure 1E ; P<0.01 vs the Sham and Sham+NaHS groups) while NaHS treatment considerably decreased the wet to dry ratio ( Figure 1E ; P<0.01 vs the HS group).
NaHS decreases rat lung protein leakage, the inflammatory response, and neutrophilic infiltration that is induced by hemo rrhagic shock The degree of hemorrhagic shock-induced lung leakage in the rat lungs was measured by the amount of protein that was present in the bronchoalveolar lavage fluid, which indicated the severity of the lung injury. We could clearly see a considerable increase in the amount of protein in the bronchoalveolar lavage fluid after hemorrhagic shock, which indicates that hemorrhagic shock increases the permeability of the lung and the leakage of protein from the blood vessels (Figure 2A ; P<0.01 vs the Sham and Sham+NaHS groups). However, the protein leakage was attenuated by the administration of NaHS (Figure 2A ; P<0.01 vs the HS group). We then analyzed the effects of NaHS on the inflammatory response to hemorrhagic shock, and the ELISA data showed an increase in the concentration of TNF-α after HS ( Figure 2B ; P<0.01 vs the Sham and Sham+NaHS groups), which was effectively attenuated by the NaHS treatment ( Figure 2B ; P<0.01 vs the HS group). Similarly, the concentration of IL-6 in the bronchoalveolar lavage fluid increased after HS (Figure 2C ; P<0.01 vs the Sham and Sham+NaHS groups). The increase in IL-6 in bronchoalveolar lavage fluid was effectively attenuated by NaHS treatment ( Figure 2C ; P<0.01 vs the HS group). There was no difference between the Sham and Sham+NaHS groups in the concentrations of IL-6 and TNF-α ( Figure 2B and 2C) .
A myeloperoxidase activity assay was performed to assess the degree of neutrophilic infiltration in the rat lungs after hemorrhagic shock. The myeloperoxidase activity in the lung tissue increased considerably after hemorrhagic shock in comparison with the Sham and Sham+NaHS groups ( Figure  2D ; P<0.01), whereas this activity was significantly reduced in the NaHS treated group (Figure 2D ; P<0.01 vs the HS group). There was no difference in the myeloperoxidase activity observed between the Sham and Sham+NaHS groups ( Figure  2D) .
Additionally, the expression of the late phase inflammatory factor HMGB1 was measured by IHC. HMGB1 expression dramatically increased after hemorrhagic shock (Figure 3C and 3E; P<0.01 vs the Sham and Sham+NaHS group). The NaHS treatment effectively reduced HMGB1 expression after HS (Figure 3D and 3E ; P<0.01 vs the HS group). However, NaHS decreases the oxidative stress that is induced by hemorrhagic shock Hemorrhagic shock increased the production of the reactive oxygen species H 2 O 2 and ·OH (Figure 4 , P<0.01 vs the Sham and Sham+NaHS groups). However, NaHS treatment notably decreased the amount of these two reactive oxygen species (Figure 4, 
P<0.01 vs the HS group).
NaHS up-regulates the translocation of Nrf2 into the nucleus and the expression of Trx1 after hemorrhagic shock Hemorrhagic shock increased the translocation of nuclear factor erythroid-2 (Nrf2) into the nucleus ( Figure 5A and 5B, P<0.05 and P<0.05 vs the Sham and Sham+NaHS groups). NaHS significantly increased Nrf2 translocation into the nucleus ( Figure 5A and 5B, P<0.05 and P<0.01 vs the HS group). Trx1 expression notably decreased after hemorrhagic shock ( Figure 5C , P<0.01 vs the Sham and Sham+NaHS groups), and NaHS administration reversed this ( Figure 5C , P<0.05 vs the HS group).
NaHS attenuates apoptosis induced by hemorrhagic shock
The data showed an obvious increase in the number of apoptotic cells in the rat lungs after HS (Figure 6C and 6E; P<0.01 vs the Sham and Sham+NaHS groups). In contrast, NaHS administration evidently alleviated the apoptotic response (Figure 6D and 6E; P<0.01 compared with HS group), and few apoptotic cells were detected in the Sham and Sham+NaHS groups ( Figure 6A and 6B) . Figure 8A, 8B ). An increase in BID expression was observed in the HS group (Figure 8A and 8C ; P<0.01 vs the Sham and Sham+NaHS groups), and NaHS treatment notably inhibited the increase in BID expression when it was compared with that observed in the HS group (Figure 8A and 8C; 
NaHS inhibits the expression of Fas and FasL during hemorrhagic shock
P<0.05).
Our data showed that hemorrhagic shock induced a notable increase in the expression of active-caspase 8 (Figure 8D  and 8E; P<0.01, P<0 .05 vs the Sham group), and NaHS treat- 
Discussion
H 2 S is recognized as a promising drug candidate and is now the subject of intense research. IK1001, an injectable H 2 S donor, was recently demonstrated to attenuate hepatic ischemia-reperfusion injury because of its anti-oxidant and anti-apoptotic properties [25] . GYY4137, a new slowly releasing hydrogen sulfide donor also was recently shown to protect against endotoxic shock in the rat at a dose of 50 mg/kg ip [26] . NaHS, an exogenous donor of H 2 S, has also been shown to be protective in a variety of animal models of disease [15] . Our previously published study demonstrated that NaHS administration ameliorated hemodynamic deterioration, the inflammatory response, and the myocardial tissue injury that are caused by hemorrhagic shock [23] . The present study supports our previous findings by examining the role of sodium hydrosulfide on hemorrhagic shock-induced lung injury in rats.
Although most of the published studies have reported that H 2 S is able to reduce a variety of organs damage in animal models of disease, Drabek et al have argued that intravenous administration of hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs [8] ; this result was not in accordance with the results reported by Blackstone [6] . Similarly, whether H 2 S has anti-or pro-inflammatory effects remains controversial. It is generally agreed that H 2 S inhibits the inflammatory response in a number of animal models of disease [7, 27] ; however, Collin et al recently reported that H 2 S acts as an inflammatory mediator in lipopolysaccharideinduced inflammation in both mice and rats [28, 29] . Additionally, a study by Mok et al proposed that H 2 S may participate in the inflammatory response to HS by inhibiting H 2 S biosynthesis [30] . However, Zanardo et al demonstrated that H 2 S modulates leukocyte adherence to the vascular endothelium by activating K ATP channels [31] . According to a new report, Seitz and colleagues showed that continuously inhaled hydrogen sulfide induces suspended animation but that it did not alter the inflammatory response to blunt chest trauma [32] . Our study shows that, although administration of a single dose of 28 μmol/kg NaHS significantly attenuated inflammation and decreased oxidative stress and apoptosis that was induced by HS, it did not induce the "suspended animation like effect" in our rat model of HS because there were no significant changes in the body temperatures observed in the experimental animals (data not shown). A single dose of NaHS, which is different from the continuously inhaled hydrogen sulfide treatment described above, may be insufficient to induce the "suspended animation like effect". Thus, in the present study, the protective effects of NaHS observed during HS-resuscitation may not be due to the "suspended animation like effect". The present study showed that HS induced significant expression of TNF-α, IL-6, and HMGB1. However, the administration of 28 μmol/kg NaHS significantly inhibited the inflammation induced by HS in rats. The key inflammatory cytokines TNF-α, IL-6, and HMGB1 decreased dramatically after the NaHS treatment, and this was accompanied by a notable attenuation of the injury that is typically induced by HS. These results were consistent with our previously published observations [33] . The aforementioned discrepancies between the anti-inflammatory and the pro-inflammatory effects of H 2 S may be due in part to the use of different animal models, different drugs and different concentrations, and may also be due in part to the administration of those drugs through different routes. Understanding these discrepancies may provide useful points of reference in the search to develop new drugs that target pathways that are modulated by H 2 S under varying conditions.
We further studied the anti-oxidative stress effects of NaHS on rat lungs after HS. Our results show that NaHS decreases the reactive oxygen species H 2 O 2 and ·OH that are induced during HS. Nrf2 is an important regulator of antioxidant expression, and we also observed that NaHS improves translocation of Nrf2 into the nucleus, which is accompanied by increased expression of Trx1. The present study was partly consistent with a very recent report, in which Li and colleagues showed that NaHS attenuated hyperoxia-induced acute lung injury that was associated with reduced oxidative stress, decreased inflammation, and reduced lung permeability in mice [34] . The inflammatory response and apoptosis are two key features of the promotion and progression of HS. The oxygen free radicals, metabolites, and cytokines that are induced by ischemia and reperfusion after resuscitation from HS participate in the organ injury, the inflammatory response and the cellular apoptosis that follow [35, 36] . Fas is an important proapoptotic factor and a member of the TNF-receptor superfamily that is expressed in a variety of cell types and tissues [37] . When it interacts with its natural ligand, FasL, Fas activates the apoptotic cascade through the caspases, thereby participating in a number of pathophysiological processes [38] . There is significant crosstalk between the apoptotic pathway and the inflammatory pathways, and the relationship between Fas/FasL and inflammation is being studied extensively. Increasing evidence now shows that the Fas/FasL system mediates inflammation, lung injury, and apoptosis in many diseases [39, 40] . Studies aimed at investigating the roles of Fas/ FasL during disease have been undertaken. Niu and colleagues reported that neutralization of FasL attenuates brain inflammation in a model of experimental stroke in mice [41] . The anti-apoptotic effects of H 2 S have been widely reported by researchers both in vivo and in vitro [42] [43] [44] . However, few studies have investigated the effects of H 2 S on HS, and even fewer have addressed the underlying mechanisms. Our study has shown that Fas and FasL expression, together with a number of other pro-apoptotic proteins, were significantly increased in rat lungs after HS and resuscitation. Administration of NaHS notably inhibited the increased expression of pro-apoptotic proteins involved in the Fas/FasL signaling pathway. As we showed in the in situ cell death assays, the apoptotic cells were primarily located in the alveolar epithelia and alveolar interstitial cells, and administration of NaHS noticeably decreased the number of apoptotic cells present in those anatomic compartments. The Bcl-2 family plays an important role in the Fas/FasL apoptotic signaling pathway. There are two members of the Bcl-2 family that serve opposing functions; Bcl-2 maintains cell survival and its closest homolog promotes apoptosis [45] . After an apoptotic signal is transmitted by FADD, caspases are activated to facilitate the progression of cellular apoptosis [46] . Our data show that the expression of the pro-apoptotic proteins BID and Bax was reduced following NaHS treatment, whereas the expression of the anti-apoptotic protein Bcl-2 increased. The increased expression of Bcl-2 protected against apoptosis caused by resuscitated HS as shown by the decreased expression of active-caspase 8, caspase 3 and FADD in the NaHS treated rats. The present study further examined the anti-apoptotic roles of H 2 S in resuscitated HS and was partially consistent with a previous study published by John et al [47] . Our results add to previous observations [25] that suggest that the anti-apoptotic effects of hydrogen sulfide protect from hepatic ischemia-reperfusion injury through antioxidant and anti-apoptotic signaling. Our data show that NaHS increases the expression of the Bcl-2 protein; however, the possibility exists that H 2 S preserves mitochondrial function by inhibiting mitochondria-dependent cell apoptosis during HS. However, this question has not yet been addressed experimentally. In summary, NaHS confers protection against lung injury in rats and inhibits lung apoptosis after hemorrhagic shock and resuscitation by attenuating the inflammatory response, decreasing oxidative stress, and inhibiting the Fas/FasL signaling pathway. These results suggest that H 2 S is a promising therapeutic drug for the treatment of lung injury caused by resuscitated HS. The possible mechanisms of the anti-apoptotic effects of NaHS are shown in Figure 9 .
